💊
Dasatinib Accord
dasatinib (anhydrous)
Precursorcellet lymfoblastisk leukæmi-lymfom; leukæmi, myelogen, kronisk, BCR-ABL positiv
🚫 Tilbagekaldt
Generisk
✅
Ingen aktive alarmer
Denne medicin har ingen igangværende mangel, sikkerhedsbreve eller tilbagekaldelser.
Hvad det bruges til
Dasatinib Accord is indicated for the treatment of adult patients with: • Ph+ acute lymphoblastic leukaemia (ALL) with resistance or intolerance to prior therapy. Dasatinib Accord is indicated for the treatment of paediatric patients with: • newly diagnosed Ph+ ALL in combination with chemotherapy.
⚠️ Patient sikkerhed
No
Officiel EMA-side
https://www.ema.europa.eu/en/medicines/human/EPAR/dasatinib-accord